Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia. (Q54367099)
Jump to navigation
Jump to search
scientific article published on 6 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia. |
scientific article published on 6 June 2011 |
Statements
Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia (English)
Ardeshir Ghavamzadeh
Kamran Alimoghaddam
Shahrbano Rostami
Mohamad Jahani
Massoud Iravani
Seyed Asadollah Mousavi